“…However, the overexpression of tyrosinase with its abnormal level in living systems would lead to severe diseases, such as skin diseases and melanoma cancer, and might also induce Parkinson’s disease. − It is reported that the survival rate of patients with early melanoma cancer can be as high as 97% if surgical treatments are received timely, whereas it is still a great challenge to diagnose and treat metastatic melanoma . Therefore, it is rather necessary to develop a sensitive and selective imaging method to assess the level of tyrosinase in various biological and pathological processes, which would provide an important reference for the diagnosis of these related diseases. − In the past years, medical imaging techniques have made great progress with the development of imaging devices and imaging probes, which have become powerful tools for monitoring and tracking in vitro and in vivo levels of various biologically important species. − Fluorescent probes have been widely employed as a powerful tool owing to their high selectivity, ultrasensitivity, and superior spatial resolution. , To date, most of them are one-photon excited fluorescent (OPEF) probes with relatively shorter excitation wavelengths; thus, the inevitable interference of background fluorescence and shallow depth of tissue penetration limit their further application in living systems. ,,,− To eliminate these deficiencies of OPEF probes, the two-photon excited fluorescent (TPEF) probes, which simultaneously absorb two photons with low energy and thus have the advantages of deep tissue penetration, less photodamage to tissues, and high spatial–temporal resolution, are taken into account. − Recently, Yoon et al reported a coumarin-based two-photon fluorescent off-on probe (TPTYR) for detecting tyrosinase activity . The TPTYR probe was constructed by incorporating 3-hydroxybenzyl that can react with tyrosinase to form a 4-methyl-7-hydroxylcoumarin, which possesses high selectivity, good sensitivity, and biocompatibility .…”